Clinical Cancer Research Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yacoub, A.
Right arrow Articles by Dent, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yacoub, A.
Right arrow Articles by Dent, P.
Clinical Cancer Research Vol. 9, 3272-3281, August 2003
© 2003 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

Melanoma Differentiation-associated 7 (Interleukin 24) Inhibits Growth and Enhances Radiosensitivity of Glioma Cells in Vitro and in Vivo1

Adly Yacoub, Clint Mitchell, Andrea Lister, Irina V. Lebedeva, Devanand Sarkar, Zao-Zhong Su, Carter Sigmon, Robert McKinstry, Viswanathan Ramakrishnan, Liang Qiao, William C. Broaddus, Rahul V. Gopalkrishnan, Steven Grant, Paul B. Fisher and Paul Dent2

Departments of Radiation Oncology [A. Y., C. M., C. S., R. M., L. Q., P. D.], Neurosurgery [A. L., W. C. B.], Medicine [S. G.], and Biostatistics [V. R.], Virginia Commonwealth University, Richmond, Virginia 23298-0058, and Departments of Pathology [I. V. L., D. S., Z-Z. S., R. G., P. B. F.], Neurosurgery [P. B. F.], and Urology [P. B. F.], College of Physicians and Surgeons, Columbia University, New York, New York 10032

ABSTRACT

Purpose: Despite therapeutic interventions including surgery, chemotherapy, and radiotherapy, glioblastoma multiforme (GBM) has a very poor prognosis and novel therapies are required.

Experimental Design: Melanoma differentiation-associated 7 (mda-7) (interleukin 24), when expressed via a recombinant replication-defective adenovirus, adenovirus (Ad).mda-7, has profound antiproliferative and cytotoxic effects in a variety of tumor cells but not in nontransformed cells. The present studies examined the combined impact of Ad.mda-7 and ionizing radiation on the proliferation and survival of GBM cell lines.

Results: Ad.mda-7 caused a dose-dependent reduction in the proliferation of glioma cells in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays. The antiproliferative effects of Ad.mda-7 were enhanced by radiation in a greater than additive fashion. These effects were not observed in cultures of nontransformed primary astrocytes. Purified MDA-7 protein caused a similar dose-dependent reduction in GBM cell growth that was enhanced after radiation exposure. The enhanced reduction in growth correlated with increased necrosis and DNA degradation. These modifications in cell phenotype correlated with reduced expression of Bcl-XL and enhanced expression of BAX. Overexpression of Bcl-XL protected cells from the antiproliferative and cytotoxic effects of Ad.mda-7 + radiation. Incubation of cells with N-acetyl cysteine abolished the enhancing effects of radiation. In vitro, Ad.mda-7 and radiation reduced colony formation ability, which was significantly increased when the two treatments were combined. In vivo, Ad.mda-7 enhanced the survival of Fischer 344 rats implanted intracranially with glioma cells. Radiation did not alter survival in control infected animals, whereas it prolonged survival in those infected with Ad.mda-7.

Conclusions: These findings demonstrate that mda-7 reduces the proliferation and enhances the radiosensitivity of GBM cells in vitro and in vivo.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
A. Yacoub, M. A. Park, P. Gupta, M. Rahmani, G. Zhang, H. Hamed, D. Hanna, D. Sarkar, I. V. Lebedeva, L. Emdad, et al.
Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells
Mol. Cancer Ther., February 1, 2008; 7(2): 297 - 313.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Yacoub, M. A. Park, D. Hanna, Y. Hong, C. Mitchell, A. P. Pandya, H. Harada, G. Powis, C.-S. Chen, C. Koumenis, et al.
OSU-03012 Promotes Caspase-Independent but PERK-, Cathepsin B-, BID-, and AIF-Dependent Killing of Transformed Cells
Mol. Pharmacol., August 1, 2006; 70(2): 589 - 603.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. V. Lebedeva, D. Sarkar, Z.-Z. Su, R. V. Gopalkrishnan, M. Athar, A. Randolph, K. Valerie, P. Dent, and P. B. Fisher
Molecular Target-Based Therapy of Pancreatic Cancer
Cancer Res., February 15, 2006; 66(4): 2403 - 2413.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. B. Fisher
Is mda-7/IL-24 a "Magic Bullet" for Cancer?
Cancer Res., November 15, 2005; 65(22): 10128 - 10138.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y. Oida, B. Gopalan, R. Miyahara, S. Inoue, C. D. Branch, A. M. Mhashilkar, E. Lin, B. N. Bekele, J. A. Roth, S. Chada, et al.
Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer
Mol. Cancer Ther., February 1, 2005; 4(2): 291 - 304.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Sauane, I. V. Lebedeva, Z.-z. Su, H.-t. Choo, A. Randolph, K. Valerie, P. Dent, R. V. Gopalkrishnan, and P. B. Fisher
Melanoma Differentiation Associated Gene-7/Interleukin-24 Promotes Tumor Cell-Specific Apoptosis through Both Secretory and Nonsecretory Pathways
Cancer Res., May 1, 2004; 64(9): 2988 - 2993.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2003 by the American Association for Cancer Research.